KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 122 filers reported holding KYMERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $70,299 | -38.9% | 5,057,425 | +1.0% | 0.01% | -37.5% |
| Q2 2023 | $115,115 | -16.7% | 5,007,148 | +7.3% | 0.02% | -23.8% |
| Q1 2023 | $138,275 | +26.5% | 4,666,681 | +6.6% | 0.02% | +16.7% |
| Q4 2022 | $109,303 | -99.9% | 4,379,159 | +6.9% | 0.02% | +20.0% |
| Q3 2022 | $89,208,000 | -13.3% | 4,097,712 | -21.6% | 0.02% | +15.4% |
| Q2 2022 | $102,874,000 | -37.6% | 5,224,686 | +34.1% | 0.01% | -23.5% |
| Q1 2022 | $164,845,000 | -26.9% | 3,895,205 | +9.7% | 0.02% | -15.0% |
| Q4 2021 | $225,423,000 | +18.7% | 3,550,528 | +9.8% | 0.02% | +11.1% |
| Q3 2021 | $189,918,000 | +112.2% | 3,233,197 | +75.2% | 0.02% | +125.0% |
| Q2 2021 | $89,479,000 | +146.8% | 1,844,926 | +97.7% | 0.01% | +100.0% |
| Q1 2021 | $36,256,000 | +49.1% | 932,978 | +138.0% | 0.00% | +100.0% |
| Q4 2020 | $24,309,000 | +155.3% | 392,076 | +33.0% | 0.00% | +100.0% |
| Q3 2020 | $9,522,000 | – | 294,695 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |